[HTML][HTML] Therapeutic response and long-term outcome of differentiated thyroid cancer with pulmonary metastases treated by radioiodine therapy

J Yang, M Liang, Y Jia, L Wang, L Lin, J Geng… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Objective To explore the therapeutic response (TR) and long-term outcomes of iodine-131 (I-
131) treatment for patients with differentiated thyroid cancer and pulmonary metastases …

Analysis of radioiodine therapy and prognostic factors of differentiated thyroid cancer patients with pulmonary metastasis: an 8-year retrospective study

R Wang, Y Zhang, J Tan, G Zhang, R Zhang, W Zheng… - Medicine, 2017 - journals.lww.com
To assess the efficacy of radioiodine therapy (RIT) and investigate the prognostic factors for
patients with pulmonary metastasis secondary to differentiated thyroid carcinoma (DTC) …

Long-term outcomes and prognostic factors of patients with lung metastases from differentiated thyroid cancer after radioiodine therapy in Japan

N Akatani, H Wakabayashi, D Kayano, A Inaki… - Endocrine …, 2023 - jstage.jst.go.jp
Long-term survival in patients with differentiated thyroid cancer (DTC) and lung metastasis
remains unexplored in Japan. This study aimed to investigate the long-term survival and …

Pulmonary metastases in differentiated thyroid cancer: efficacy of radioiodine therapy and prognostic factors

HJ Song, ZL Qiu, CT Shen, WJ Wei… - European Journal of …, 2015 - academic.oup.com
Context Data from a large cohort of patients with pulmonary metastases from differentiated
thyroid cancer (DTC) were retrospectively analyzed. Objective To assess the effect of …

The Effect of Radioiodine Therapy on the Prognosis of Differentiated Thyroid Cancer with Lung Metastases

S Zhang, M Zhu, H Zhang, H Liu, X Fan, J Zhang, F Yu - Biomedicines, 2024 - mdpi.com
Lung metastasis substantially influences the survival of thyroid cancer (TC) patients. This
study sought to investigate factors impacting the survival of differentiated thyroid cancer …

The predictive values of lesion size, f-18 FDG avidity and I-131 avidity for the clinical outcome of I-131 treatment in patients with metastatic differentiated thyroid …

JH Choi, BH Byun, I Lim, H Moon, J Park… - Nuclear Medicine and …, 2018 - Springer
Purpose We aimed to evaluate the prognostic values of radiography, F-18 FDG PET, and I-
131 whole body scans in patients with lung-only metastasis from differentiated thyroid …

Long-term outcomes of differentiated thyroid cancer with only lung metastasis and the prognostic factors

JH Choi, H Moon, J Park, K Chang, BH Byun, I Lim… - 2015 - Soc Nuclear Med
1260 Objectives The aim of this study was to investigate the long-term outcomes of only lung
metastasis in differentiated thyroid cancer (DTC) patients and the prognostic factors …

Risk factors for nonremission and progression-free survival after I-131 therapy in patients with lung metastasis from differentiated thyroid cancer: a single-institute …

P Chen, H Feng, W Ouyang, J Wu, J Wang, Y Sun… - Endocrine Practice, 2016 - Elsevier
Objective: Prognostic factors related to progression-free survival (PFS) have not received
much attention in the literature regarding iodine-131 (131 I) therapy for patients with …

Efficacy of radioiodine therapy for treating 20 patients with pulmonary metastases from differentiated thyroid cancer and a meta-analysis of the current literature

X Zhang, DS Liu, ZS Luan, F Zhang, XH Liu… - Clinical and …, 2018 - Springer
Background Radioiodine therapy (RAI) after total or near-total thyroidectomy is a
recommended treatment for patients with pulmonary metastasis from differentiated thyroid …

Long-term survival and low effective cumulative radioiodine doses to achieve remission in patients with 131Iodine-avid lung metastasis from differentiated thyroid …

F Pitoia, F Bueno, G Cross - Clinical Nuclear Medicine, 2014 - journals.lww.com
Long-Term Survival and Low Effective Cumulative Radioiodine... : Clinical Nuclear Medicine
Long-Term Survival and Low Effective Cumulative Radioiodine Doses to Achieve Remission in …